2021. Changes in the concentration of EGFR-mutated plasma DNA in the first hours of anti-EGFR therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer. Voprosy onkologii. 67, 5 (Oct. 2021), 665–674. DOI:https://doi.org/10.37469/0507-3758-2021-67-5-665-674.